SUMMARY Five children under the age of 9 years had topical chloramphenicol drops administered 2-hourly to each eye for 5 to 7 days. Systemic absorption was not detected by 2 sensitive assays for the drug. The hazards of topical chloramphenicol and reports in the current literature are discussed.
Two cases of suspected bone marrow depression due to topical application of chloramphenicol eyedrops have been reported (Rosenthal and Blackman, 1965; Carpenter, 1975 ), yet there has not been a published report on the systemic absorption of this drug from the human eye. It is known, however, that topically applied chloramphenicol is absorbed into the aqueous humour in man (Beasley et al., 1975) and animals (George and Hanna, 1977) ; systemic absorption of the antibiotic has been detected after topical administration to the eye in animals.
Methods and materials
Five children under 9 years of age, all admitted for routine squint surgery, were given chlorampenicol topically (0 5% chloramphenicol Redidrops) 2-hourly to each eye over a 5 to 7 day period until a dose of between 40 and 52 mg of chloramphenicol had been administered (Table 1) . Urine samples were collected within 24 hours of the last dose. These samples were subjected to analysis by gasliquid chromatography (Least et al., 1977) which with thiamphenicol as internal standard had a lower limit of sensitivity of 1 ,ug/ml. Polarography was also performed on these samples with a Southern Analytical Davies Diffraction Cathode Ray Oscilloscope. This method was found to be sensitive to levels of chloramphenicol from 0 05 jig/ ml upwards when aqueous standards were examined. However, because of non-specific interference from the drug-free urine the practical working limit of the assay proved to be 1 ,ug/ml.
Results
These assays failed to detect any chloramphenicol in urine following the dosage schedules outlined. This was the case even when the extraction procedures described above were modified to allow concentration by a factor of 10:1. It thus appears that any chloramphenicol reaching the urine after ocular administration does not attain concentrations exceeding 0-1 ,ug/ml.
Discussion
The primary excretory pathway for chloramphenicol is via the kidneys; 80 to 900o of an oral dose is eliminated this way within 24 hours of administration (Goodman and Gilman, 1975) . If systemic absorption of chloramphenicol is suspected from the eye, one would expect chloramphenicol to appear in the urine in higher concentrations than in the plasma. This effect has been confirmed in animal studies (Conner and Gupta, 1973 Carpenter (1975) did not provide a definite link between this drug and the aplasia. The aplasia reported by Rosenthal and Blackman (1965) , however, may well have been precipitated by chloramphenicol drops, as this patient had a strong family history of fatal aplastic anaemia precipitated by oral chloramphenicol therapy and had used topical drops for an extremely long time, namely, 2 years. In this type of case the possibility of fatal or serious results must be considered, as the likelihood of systemic absorption must be higher than in the shorter periods described above.
Conclusion
Chloramphenicol is a widely used effective topical antibiotic. Even though we were unable to detect systemic absorption of this drug after topical application to both eyes in children over a 5 to 7 day period, the possibility, however remote, still exists that systemic absorption may occur if the drug is used for excessively long periods of time. Ophthalmic practitioners should be alert to this potential hazard and its complications. Further studies to detect systemic absorption of this drug over very long periods, preferably in inflamed eyes, are indicated. 
